SCHEMBL21675693

SCHEMBL21675693

Nc1onc(-c2ccccc2)c1-c1ccc(S(N)(=O)=O)cc1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 11/20 0.72
CA2 P00918 9/20 0.72
CA1 P00915 8/20 0.72
CA9 Q16790 7/20 0.72
CA12 O43570 6/20 0.72
CA4 P22748 2/20 0.72
CA7 P43166 2/20 0.72
MT-CO2 P00403 1/20 0.72
LMNA P02545 1/20 0.72
CA3 P07451 1/20 0.72
ADRB2 P07550 1/20 0.72
ADRB1 P08588 1/20 0.72
CYP3A4 P08684 1/20 0.72
ADORA3 P0DMS8 1/20 0.72
CHRM1 P11229 1/20 0.72
ADRA2B P18089 1/20 0.72
PTGS1 P23219 1/20 0.72
CA6 P23280 1/20 0.72
SLC6A2 P23975 1/20 0.72
PDE4A P27815 1/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Valdecoxib SCHEMBL3853130 0.84 PTGS2 (1.00) PTGS2CA2CA1CA9CA12
Valdecoxib SCHEMBL3356 0.84 PTGS2 (1.00) PTGS2CA2CA1CA9CA12
SCHEMBL14267626 0.84 PTGS2 (0.71) PTGS2CA2CA1CA9CA12
SCHEMBL4810298 0.84 PTGS2 (0.71) PTGS2CA2CA1CA9CA12
SCHEMBL6168344 0.84 PTGS2 (1.00) PTGS2CA2CA1CA9CA12
SCHEMBL5322447 0.84 PTGS2 (0.71) PTGS2CA2CA1CA9CA12
SCHEMBL214781 0.83 PTGS2 (0.66) PTGS2CA2CA1CA9CA12
Valdecoxib SCHEMBL6601157 0.83 PTGS2 (0.97) PTGS2CA2CA1CA9CA12
SCHEMBL3861413 0.83 PTGS2 (1.00) PTGS2CA2CA1CA9CA12
Valdecoxib SCHEMBL5999213 0.83 PTGS2 (0.97) PTGS2CA2CA1CA9CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3693022-A2 COX-2-TARGETING, PLATINUM-CONTAINING CONJUGATES AND THEIR USE IN THE TREATMENT OF TUMORS AND CANCERS Reiley Pharmaceuticals, Inc. (US) 2020-08-12 EP disclosed
EP-3242688-B1 COX-2-TARGETING, PLATINUM-CONTAINING CONJUGATES AND THEIR USE IN THE TREATMENT OF TUMORS AND CANCERS REILEY PHARMACEUTICALS INC (US) 2020-01-29 EP disclosed